Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiaoming Yang
Observed name:
Xiao-ming Yang
Institutions:
China National Pharmaceutical Group Corporation (China),
China National Biotechnology (China)
Observed institutions:
China National Pharmaceutical Group Corporation (China),
China National Biotechnology (China)
ORCID:
0000-0001-9711-6904
Observed ORCID:
0000-0001-9711-6904
OpenAlex ID:
A5016593849
Amino Acids 1055 to 1192 in the S2 Region of Severe Acute Respiratory Syndrome Coronavirus S Protein Induce Neutralizing Antibodies: Implications for the Development of Vaccines and Antiviral Agents
2005
·
Choong-Tat Keng
, Aihua Zhang
, et al.
·
Journal of Virology
·
105
PDF
The severe acute respiratory syndrome coronavirus 3a is a novel structural protein
2005
·
Shuo Shen
, Pi-Shiu Lin
, et al.
·
Biochemical and Biophysical Research Communications
·
99
PDF
A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro
2008
·
Xiaohua Wang
, Wei Xu
, et al.
·
Immunology Letters
·
24
PDF
Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine
2023
·
Changrui Lu
, Yuntao Zhang
, et al.
·
Antiviral Research
·
12
Cellular tropism and antigenicity of mink-derived SARS-CoV-2 variants
2021
·
Li Zhang
, Qianqian Li
, et al.
·
Signal Transduction and Targeted Therapy
·
9
PDF
A cross-sectional seroepidemiology study of seven major enteroviruses causing HFMD in Guangdong, China
2021
·
Fan Gao
, Lian-lian Bian
, et al.
·
Journal of Infection
·
7
Innovation-driven trend shaping COVID-19 vaccine development in China
2023
·
Yuntao Zhang
, Yuxiu Zhao
, et al.
·
Frontiers of Medicine
·
2
Show more works
View as search
Works count:
7
Citation count:
258
H-index:
6
I10-index:
4
Year
Topic
Type